Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
83.35
-1.50 (-1.77%)
May 5, 2025, 4:00 PM EDT - Market closed
Medtronic Revenue
Medtronic had revenue of $8.29B in the quarter ending January 24, 2025, with 2.51% growth. This brings the company's revenue in the last twelve months to $33.20B, up 2.72% year-over-year. In the fiscal year ending April 26, 2024, Medtronic had annual revenue of $32.36B with 3.64% growth.
Revenue (ttm)
$33.20B
Revenue Growth
+2.72%
P/S Ratio
3.26
Revenue / Employee
$349,463
Employees
95,000
Market Cap
107.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 26, 2024 | 32.36B | 1.14B | 3.64% |
| Apr 28, 2023 | 31.23B | -459.00M | -1.45% |
| Apr 29, 2022 | 31.69B | 1.57B | 5.21% |
| Apr 30, 2021 | 30.12B | 1.20B | 4.16% |
| Apr 24, 2020 | 28.91B | -1.64B | -5.38% |
| Apr 26, 2019 | Pro | Pro | Pro |
| Apr 27, 2018 | Pro | Pro | Pro |
| Apr 28, 2017 | Pro | Pro | Pro |
| Apr 29, 2016 | Pro | Pro | Pro |
| Apr 24, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Thermo Fisher Scientific | 42.90B |
MDT News
- 5 days ago - Smart Pills Market Industry Trend Analysis, and Forecast 2025-2034, with Profiles of ANX Robotica, Bodycap, CapsoVision, Check-Cap, etectRx, Intromedic, Medtronic, Otsuka, Olympus and RF - GlobeNewsWire
- 6 days ago - Best Dividend Aristocrats For May 2025 - Seeking Alpha
- 9 days ago - Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients - PRNewsWire
- 9 days ago - Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system - PRNewsWire
- 10 days ago - Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results - PRNewsWire
- 11 days ago - Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump - PRNewsWire
- 12 days ago - Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting - GlobeNewsWire
- 12 days ago - Medtronic: Time To Buy This Dividend Aristocrat Bargain - Seeking Alpha